{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:13:11Z","timestamp":1784355191856,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22201267"],"award-info":[{"award-number":["22201267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LTGD24C080001"],"award-info":[{"award-number":["LTGD24C080001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008773","name":"Hainan Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bmcl.2025.130437","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:13:49Z","timestamp":1760220829000},"page":"130437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of N-Ts-3-benzylidene-indolin-2-imines as potent anti-colorectal cancer agents through suppression of the PI3K-AKT pathway"],"prefix":"10.1016","volume":"130","author":[{"given":"Chuan-Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Gao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2025.130437_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13046-025-03357-z","article-title":"USP10\/XAB2\/ANXA2 axis promotes DNA damage repair to enhance chemoresistance to oxaliplatin in colorectal cancer","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130437_bb0010","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.3390\/ijms24087597","article-title":"Colorectal cancer chemoprevention: a dream coming true?","volume":"24","author":"Signorile","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130437_bb0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3322\/caac.21728","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA-Cancer J Clin"},{"issue":"30","key":"10.1016\/j.bmcl.2025.130437_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk9878","article-title":"Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity","volume":"10","author":"Sung","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmcl.2025.130437_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130437_bb0030","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130437_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130437_bb0040","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/ijms25063178","article-title":"PI3K\/Akt\/mTOR signaling pathway as a target for colorectal cancer treatment","volume":"25","author":"Leiphrakpam","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130437_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176727","article-title":"Targeting the RAS upstream and downstream signaling pathway for cancer treatment","volume":"979","author":"Hossain","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"35","key":"10.1016\/j.bmcl.2025.130437_bb0050","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"Yap","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130437_bb0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10637-015-0212-z","article-title":"Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer","volume":"33","author":"Do","year":"2015","journal-title":"Investig New Drugs"},{"key":"10.1016\/j.bmcl.2025.130437_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112827","article-title":"Advances in indole-containing alkaloids as potential anticancer agents by regulating autophagy","volume":"149","author":"Luo","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2025.130437_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116594","article-title":"Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K\/AKT\/mTOR pathway","volume":"55","author":"Qin","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130437_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114971","article-title":"Recent advances in PI3K\/PKB\/mTOR inhibitors as new anticancer agents","volume":"246","author":"Occhiuzzi","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"Part 2","key":"10.1016\/j.bmcl.2025.130437_bb0075","article-title":"Design, synthesis and molecular docking of 5-fluoro indole derivatives as inhibitors of PI3K\/Akt signalling pathway in cervical cancer","volume":"1312","author":"Etikyala","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2025.130437_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118203","article-title":"Discovery of tetracyclic 1,2,4-triazoline-fused dibenzo[b,f][1,4]oxazepine as a potent anti-colorectal cancer agent with good efficacy and low toxicity","volume":"125","author":"Shi","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130437_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216965","article-title":"Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: new cues for cancer chemotherapy","volume":"594","author":"Palominos","year":"2024","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130437_bb0090","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jpp\/rgab092","article-title":"O2-(2,4-dinitrophenyl) diazeniumdiolate derivative induces G2\/M arrest via PTEN-mediated inhibition of PI3K\/Akt pathway in hepatocellular carcinoma cells","volume":"73","author":"Liu","year":"2021","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130437_bb0095","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1039\/D4MD00389F","article-title":"Structure-based virtual screening discovers novel PKMYT1 inhibitors","volume":"15","author":"Zhang","year":"2024","journal-title":"RSC Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130437_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111603","article-title":"Revisiting phosphoregulation of Cdc25C during M-phase induction","volume":"28","author":"Tan","year":"2025","journal-title":"iScience"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T08:15:06Z","timestamp":1761639306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"alternative-id":["S0960894X25003464"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130437","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of N-Ts-3-benzylidene-indolin-2-imines as potent anti-colorectal cancer agents through suppression of the PI3K-AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130437"}}